Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo.
about
Theiler's virus infection: a model for multiple sclerosisGenome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipientsMeasles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen.Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of higEnhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivoRole of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infectionExpression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.Creation of killer poxvirus could have been predictedExpression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo.Role of gamma interferon in cellular immune response against murine Encephalitozoon cuniculi infection.Lack of CD4(+) T cells does not affect induction of CD8(+) T-cell immunity against Encephalitozoon cuniculi infection.Ocular infection of mice with an avirulent recombinant HSV-1 expressing IL-4 and an attenuated HSV-1 strain generates virulent recombinants in vivo.Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy.Reduced interleukin-4 receptor α expression on CD8+ T cells correlates with higher quality anti-viral immunity.Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switchingNK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia virusesIL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse.Modification of the Sendai virus-specific antibody and CD8+ T-cell responses in mice homozygous for disruption of the interleukin-4 gene.Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus.Temporal Characterization of Marburg Virus Angola Infection following Aerosol Challenge in Rhesus Macaques.Virally delivered cytokines alter the immune response to future lung infectionsIL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccineVaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response.Vaccinia virus vaccines: past, present and future.Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination.The roles of chemokines in rabies virus infection: overexpression may not always be beneficial.Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responses.Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.Recombinant herpes simplex virus type 1 expressing murine interleukin-4 is less virulent than wild-type virus in mice.T-bet is required for protection against vaccinia virus infection.Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major.T-cell immune response against cytomegalovirus in peripheral blood and colonic mucosa from ulcerative colitis and Crohn's disease patients.Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory.
P2860
Q24629115-E9D6DFE8-9832-4AA0-8960-06EAEF83BE30Q28943252-52EC429C-9A5E-47B8-9524-4ECA038671A2Q33782534-38390DCD-095C-4834-A0B8-04550B8A593AQ33782766-B4E5683E-2A93-4BA7-906B-49C132F20C2DQ33786257-EC2BE6F8-D8DD-4944-8AE0-541A550F2F84Q33822233-EBFD701D-5E6E-460C-A2A5-127CC74C11FAQ33835324-CDC338B1-F95D-4C8A-9201-9DC78C181C38Q33836059-404FD1CF-2611-4F30-9FE6-E6DBA82848A0Q33853781-9CEB0EAC-C1DA-458F-9B8A-6D36011D6ACFQ33908872-27E45B5B-7D8F-48AE-96C0-CDE19F8FE344Q33998592-55DC65FD-1CB7-4D2C-9262-E17C3745BD8CQ34000936-E9E88574-BB47-40D6-A949-826F654991ACQ34004978-C8496972-8AE7-4AF3-9385-06549DCFD735Q34364070-F0D80CAB-909A-46AB-817F-3FBA3B0B0970Q34432037-AFD48DFE-E540-4A28-AC7F-E786407073F8Q34576972-814844A5-6ED7-46B0-9A84-264F2A57B06DQ34810232-763CE3ED-3D01-4AD9-AF67-EC70C5B8DD96Q34999264-B08D0BDA-AB7D-4031-875B-714873C0F4D3Q35023470-A55D003E-8E21-4DB4-9CAA-A7C138F070FAQ35665094-6319F768-B0A6-4B1B-8ED2-7E5DCBBE1FC3Q35879845-0B8B886A-898C-47E0-B674-C7C20E9257F5Q35898832-86C0BAEC-FA0C-4951-A89A-F5CC2E5EB9ADQ36080908-EAA55477-5C23-447F-BDC3-AD98F29B0A8FQ36315800-23E1BCAE-5119-455B-A46F-3804C5946701Q36972168-1D0A5CDF-85FE-4B0A-8887-6FB27C5298ACQ37329533-A047EC45-D7E9-4B8F-901E-291AA2674947Q37343595-FEB88949-7B0A-4656-A3C1-8D052095162AQ37375372-843E447E-D83E-47BC-A992-DFBC9F632B4CQ37410626-1C9A4694-56E0-475A-927C-75261B98CD7DQ37414801-EB6C8B4B-03B1-4B72-840D-3749B28BD296Q37596586-4A596EBD-8925-47FE-A7BE-E9DABA1A850FQ38264652-93AF942D-CD14-4F62-8166-915EF1709A90Q39604013-CE8CF681-72BF-42D8-89BA-010F0C1D1CFEQ42094910-AD5CA6D0-C283-402C-B925-F466D9A71E4BQ44116952-28361C26-6721-46AC-8EED-91AED87747A1Q49179963-16823F9E-2B3F-497D-A2CB-38E6B87A24D8Q50533334-52A60B14-6020-42A0-9C38-4D0291B03791
P2860
Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Interleukin-4 mediates down re ...... cinia virus infection in vivo.
@ast
Interleukin-4 mediates down re ...... cinia virus infection in vivo.
@en
type
label
Interleukin-4 mediates down re ...... cinia virus infection in vivo.
@ast
Interleukin-4 mediates down re ...... cinia virus infection in vivo.
@en
prefLabel
Interleukin-4 mediates down re ...... cinia virus infection in vivo.
@ast
Interleukin-4 mediates down re ...... cinia virus infection in vivo.
@en
P2093
P2860
P1433
P1476
Interleukin-4 mediates down re ...... cinia virus infection in vivo.
@en
P2093
P2860
P304
P407
P577
1996-10-01T00:00:00Z